About: Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

clinical trial

Attributes	Values
rdf:type	Item
description	clinical trial (en) ensayu clínicu (ast) klinisch onderzoek (nl) клінічне випробування (uk)
rdfs:label	Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer (en) Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer (nl)
skos:prefLabel	Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer (en) Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer (nl)
name	Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer (en) Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer (nl)
title	wds:Q66037138-19BBA0B3-43FF-4B61-A640-CE0A3D77C0E4
title	A Phase II Study Of Oxaliplatin (OXAL), 5-Fluorouracil (5-FU), Leucovorin (CF), and Cetuximab (C225) For Patients With Unresectable Hepatic Metastases From Metastatic Adenocarcinoma Of The Colon Or Rectum (en)
end time	wds:Q66037138-25C6C3EE-16C2-490F-B96D-9B5DA12169A7
end time	2007-10-01 00:00:00Z (xsd:dateTime)
instance of	wds:Q66037138-F1FB24A6-F2E3-48E3-8366-3EED0E0C68A4
instance of	clinical trial
start time	wds:Q66037138-26EADA7F-0818-4196-9D8D-1ECB503995CD
start time	2004-12-01 00:00:00Z (xsd:dateTime)
country	wds:Q66037138-201266F5-C087-4E36-B031-E996734F69E7
country	United States of America
main subject	wds:Q66037138-F7C2B8EE-D567-4582-8E94-EFD712183310
main subject	rectum adenocarcinoma
research site	wds:Q66037138-0F48F84C-819F-4C7E-A885-84CEC9BE9F87 wds:Q66037138-4F20C7B6-2905-42D4-8724-0976218A0CFD wds:Q66037138-58E42656-06FE-43E5-A971-F1CF5A75D50B wds:Q66037138-78A2473C-9CCA-44CE-88A9-8CCA121C486E wds:Q66037138-979F2F1D-31B7-4394-9CE8-223F54AD00A6 wds:Q66037138-D6B98332-C12C-4EC2-8DD3-F47D975FDFE0 wds:Q66037138-E02A87F5-E3CD-45A9-A9A2-77B4EB09B338
research site	Allegheny General Hospital Creighton University Coborn Cancer Center Park Nicollet Methodist Hospital Metro-Minnesota Community Oncology Research Consortium Iowa Methodist Medical Center Guthrie Clinic
research intervention	wds:Q66037138-A5FC491C-E7F3-4AC5-A2DD-8A691D571CA2 wds:Q66037138-B90BA61F-2BCE-44AE-9637-8DF95DBFA8D0 wds:Q66037138-EAB5A803-026E-490E-A9A5-6CD79F5C3958
research intervention	wd:Q238512 calcium oxalate leucovorin calcium
minimum age	wds:Q66037138-A353F5B4-50BE-44F2-96CB-B6B5F2C61DF8
minimum age	18 (xsd:decimal)
medical condition	wds:Q66037138-89217EE1-4E1C-425C-87ED-E545E16A0E61
medical condition	adenocarcinoma
number of participants	wds:Q66037138-CC7C53EE-4A32-4BAE-962E-1FD77CA1DBDA
number of participants	73 (xsd:decimal)
study type	wds:Q66037138-2CEFA4D6-339A-4C6F-ADAB-DE2B20C7CA63
study type	interventional study
ClinicalTrials.gov ID	wds:Q66037138-2487A54C-31AE-4AE4-9CEB-C25945840391
ClinicalTrials.gov ID	NCT00056030
clinical trial phase	wds:Q66037138-560171B8-DDA6-4C4A-ABC4-14CBDFAE30F7
clinical trial phase	phase II clinical trial
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q66037138

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software